DRAXIMAGE DTPA DIN 02329727
Health Canada record
| Active ingredient(s) | PENTETIC ACID 20 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Inhalation; Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | 19-Apr-2002 |
| Current status date | 13-Jun-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jubilant Draximage Inc. dba Jubilant Radiopharma — licence 101869, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
International API supply for PENTETIC ACID
1 active FDA Drug Master Files.
Request a quote for DRAXIMAGE DTPA